Instant
Regulatory panel clears Serum Institute’s vaccine candidate ‘Covishield’ for emergency use
Regulatory panel clears Serum Institute’s vaccine candidate ‘Covishield’ for emergency use
Subject Expert Committee (SEC) granted Emergency Use Authorization (EUA) for Covishield
A final application will be sent to DCGI before the rollout
Bharat Biotech developed the vaccine in collaboration with ICMR
A national expert panel has suggested vaccinating 30 crore people in the first half of 2021
Leave a Reply